CQ Guide: How to Embrace Digital Transformation throughout Medical Device Value Chain
Due to the disruptions in the global supply chains, many manufacturers have had to quickly adapt to the changing market conditions to meet consumer expectations while navigating the complex and time-consuming regulatory approval process.
In response to the disruptions, some manufacturers have shifted their focus to producing essential goods, such as Personal Protective Equipment (PPE) and medical supplies, to meet the urgent needs of healthcare workers and others on the front lines of the pandemic. Others have had to adjust their manufacturing processes to keep up with changes in demand or to find alternative sources for raw materials and components that may have become scarce due to supply chain disruptions.
At the same time, manufacturers must continue to navigate the regulatory approval process, which can be challenging and time-consuming even under normal circumstances. In many cases, regulatory agencies have implemented emergency measures to expedite the approval of critical products related to the pandemic. However, manufacturers must still meet rigorous safety and efficacy standards to bring their products to market.
